Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma

02 March 2023

A comprehensive guide on how to approach fertility-sparing treatment in endometrial cancer, written in an international collaboration with leading experts from ESHRE, the European Society of Gynaecological Oncology (ESGO) and the European Society for Gynaecological Endoscopy (ESGE) is now published in Human Reproduction Open, and simultaneously in the International Journal of Gynecological Cancer, and Facts, Views, & Vision in ObGyn.

Mothers’ alcohol consumption before and during pregnancy is linked to changes in children’s face shapes

16 February 2023

Human Reproduction Press Release
Researchers have used artificial intelligence (AI) and deep learning technology to find a link between alterations in the shape of children’s faces and the amount of alcohol their mothers drank, both before becoming pregnant and during pregnancy.

ESHRE updated the evidence-based guideline on recurrent pregnancy loss

01 February 2023

The updated guideline is now available. The guideline development group hope to ensure this guideline remains relevant and useful to clinical practice, with this updated edition reflecting the latest published studies in the field.

We believe this update will provide even more value to members who rely on the 2017 version for the care and management of women with recurrent pregnancy loss.

Registration for ESHRE 2023 is now open

09 January 2023

We are hopeful that you can all join us for our Annual Meeting to celebrate the world’s largest in-person event in reproductive science and medicine. This 39th annual meeting will be planned primarily as a traditional in-person meeting with the support of live-streamed broadcast presentations from the scheduled live scientific sessions. On-demand access to all presentations will be available to all registrants.